Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Amarin Corp Ads (NQ: AMRN )

5.110 USD +0.030 (+0.59%)
Official Closing Price Updated: 7:58 PM EDT, Apr 14, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Amarin Corp Ads

< Previous 1 2 3 4 5 6 7 8 9
...
89 90 Next >
Appeals Court Rules Against Amarin in Vascepa Patent Dispute
Just one day after hearing arguments, the U.S. Court of Appeals delivered a ruling that Amarin shareholders did not want to hear. 
Tags HIK AMRN Market News
From Motley Fool
Amarin Provides Update Following Ruling in VASCEPA® ANDA Patent Litigation
From GlobeNewswire News Releases
Return On Capital Employed Overview: Amarin Corp
Amarin Corp (NASDAQ: AMRN) posted Q2 earnings of $4.16 million, an increase from Q1 of 117.3%. Sales dropped to $135.32 million, a ... 
Tags Market News Earnings Benzinga
From Benzinga
Amarin Shares Have Downside To $3 On Patent Loss, Says Northland
An unfavorable Vascepa patent ruling from the Court of Appeals Federal Circuit can place the shares of Amarin in the $3 range, Northland analyst Carl Byrnes tells investors in a research note. 
Tags Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
52 Biggest Movers From Yesterday
Gainers Corcept Therapeutics Incorporated (NASDAQ: CORT) shares jumped 58.5% to close at $19.87 on Wednesday following Form 4 ... 
Tags BRQS VRA ADTX
From Benzinga
Why Amarin Stock Is Getting Slammed Today
An appeal hearing for Vascepa's patent case isn't sitting well with investors. 
Tags RDY HKMP/F Market News
From Motley Fool
Amarin plummets 31% after appeal hearing related to its heart drug is 'incrementally negative,' analyst says to not buy shares (AMRN)
From Business Insider
Why Amarin Shares Are Plunging Wednesday
Amarin Corporation plc (NASDAQ: AMRN) shares were plummeting on above-average volume as an appeal hearing on the Vascepa fish oil ... 
Tags Vascepa AMRN Analyst Ratings
From Benzinga
44 Stocks Moving In Wednesday's Mid-Day Session
Gainers Lonestar Resources US Inc. (NASDAQ: LONE) shares climbed 42.3% to $0.3801 after declining 10% on Tuesday. The company ... 
Tags GRAF HLNE Trading Ideas
From Benzinga
Amarin Sinks After Vascepa Patent Trial Judges Are Revealed
Shares of Amarin moved lower after the judges were posted for the company's Federal Circuit appeal of the Vascepa patent invalidation versus generics. 
Tags Healthcare Stocks / Equities
From Blogs - TalkMarkets
Thinking about buying stock in Advanced Micro Devices, Lonestar Resources, Amarin Corp, SmileDirectClub, or Vera Bradley?
InvestorsObserver issues critical PriceWatch Alerts for AMD, LONE, AMRN, SDC, and VRA. 
From PR Newswire
The Daily Biotech Pulse: Amarin's Vascepa Appeal Hearing, Avid Bioservices' Strong Q1, A Life Sciences Blank Check IPO
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1) 10X Genomics Inc (NASDAQ: TXG) Acutus Medical Inc (NASDAQ: ... 
Tags TWST ITOS EVGN
From Benzinga
Amarin Supports Latest Clinical Research Evaluating VASCEPA® (Icosapent Ethyl) in Patients with Persistent Cardiovascular Risk Presented at ESC Congress 2020, the Annual Meeting of the European Societ
From GlobeNewswire News Releases
60 Biggest Movers From Yesterday
Gainers Aimmune Therapeutics, Inc (NASDAQ: AIMT) shares jumped 171.6% to close at $34.22 on Monday after Nestle SA agreed to ... 
Tags Markets SHLO UONE
From Benzinga
50 Stocks Moving In Monday's Mid-Day Session
Gainers Aimmune Therapeutics, Inc (NASDAQ: AIMT) shares climbed 171.5% to $34.21 after Nestle SA agreed to acquire the company at ... 
Tags DXLG GTX TAT
From Benzinga
50 Stocks Moving In Monday's Mid-Day Session
Gainers Aimmune Therapeutics, Inc (NASDAQ: AIMT) shares climbed 171.5% to $34.21 after Nestle SA agreed to acquire the company at ... 
Tags Benzinga BIGC Penny Stocks
From Benzinga
Thinking about buying stock in Aimmune Therapeutics, FSD Pharma, Amarin Corp, Trevena Inc, or American Airlines?
InvestorsObserver issues critical PriceWatch Alerts for AIMT, HUGE, AMRN, TRVN, and AAL. 
From PR Newswire
38 Stocks Moving in Monday's Pre-Market Session
Gainers Aimmune Therapeutics, Inc (NASDAQ: AIMT) shares rose 169.8% to $34.00 in pre-market trading after Nestle SA agreed to ... 
Tags Market News HJLI NBIX
From Benzinga
The Week Ahead In Biotech (Aug. 30- Sept. 5): Bristol-Myers Squibb FDA Decision, Adcom Review For Glaxo, Amarin Vascepa Hearing
Biotech stocks went about a consolidation move in the week ended Aug. 28 amid thin news flow. Barringupdates on coronavirus ... 
Tags CUE Market News AZN
From Benzinga
VASCEPA® (Icosapent Ethyl) Reported to Significantly Reduce Coronary Plaque in EVAPORATE Study Final Results Presented at ESC Congress 2020
From GlobeNewswire News Releases
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Featured in Editorial Projecting Significant Growth for Global Brain Tumor Therapeutics Sector
From InvestorBrandNetwork
Global Brain Tumor Therapeutics Market Targeted to Reach $3.4 Billion by 2025
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Global Brain Tumor Therapeutics Market Targeted to Reach $3.4 Billion by 2025
Financialnewsmedia.com News Commentary 
From PR Newswire
Why Amarin's Stock Is Trading Higher Today
Amarin Corp (NASDAQ: AMRN) shares are trading higher on Wednesday after Piper Sandler initiated coverage on the company's stock with ... 
Tags Market News Price Target why it's moving
From Benzinga
Benzinga's Top Upgrades, Downgrades For August 26, 2020
Upgrades Evercore ISI Group upgraded the previous rating for The Hain Celestial Group Inc (NASDAQ: HAIN) from In-Line to ... 
Tags Market News top upgrades AOSL
From Benzinga
How The Parts Add Up: PPH Headed For $75
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Cramer Gives His Opinion On Livongo Health, DR Horton And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said Livongo Health Inc (NASDAQ: LVGO) is coming back. The merger with ... 
Tags EQT Media mad money Lightning Round
From Benzinga
Latest Clinical Research Evaluating VASCEPA® (Icosapent Ethyl) in Patients with Residual Cardiovascular Risk to be Presented at ESC Congress 2020, the Annual Meeting of the European Society of Cardiol
Amarin-Supported Research and Analyses from Academic Collaborators to Be Featured in Five Presentations, Including Late-Breaking Science Presentation of Final EVAPORATE Study Results 
From GlobeNewswire News Releases
Amarin Supports Investigator-Initiated Trial at Kaiser Permanente in the U.S. to Study the Effects of VASCEPA® (icosapent ethyl) in Reducing Viral Upper Respiratory Infections, Including COVID-19 and
From GlobeNewswire News Releases
4 Reasons Amarin Stock Could Tumble Even Further
The company's second-quarter earnings report was less than encouraging. 
Tags Market News AMRN
From Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
89 90 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.